复合激活因子VIIa与特兰胺酸结合控制尿道手术的重症因子XI缺乏症患者的血液静止
Neta Sternbach1, Yaron Ehrlich2, Anfisa Stenevsky1
1Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center Petah-Tikva, Petah-Tikva, Israel.
概括
这项研究表明,将重组激活的第七因子 (rFVIIa) 与松酸 (TXA) 结合起来,是治疗在接受泌尿外科手术的严重XI因子缺乏症患者出血风险的安全有效方法.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的XI因子缺乏症在泌尿器科手术期间存在显著的出血风险.
- 特兰胺酸 (TXA) 的使用因潜在的血栓形成而复杂化.
- 基于等离子体的治疗有局限性;非标签的重组激活因子VII (rFVIIa) 在一般外科手术中表现有前途.
研究的目的:
- 评估结合rFVIIa与TXA在泌尿外科手术中的疗效和安全性.
- 评估这种方法在具有高纤维解酶活性的患者中.
主要方法:
- 七名患有严重XI因子缺乏症的患者进行了回顾性分析,这些患者接受了泌尿器科手术.
- 患者接受了TXA和非标签的rFVIIa.a的单次术前剂量.
- 术后监测尿路出血和血栓性并发症.
主要成果:
- 所有手术都没有出现显著的出血并发症,除了阿司匹林患者的一例可控例外.
- 没有患者需要因凝块,输血或额外的rFVIIa剂量而停止TXA治疗.
- 没有观察到血栓性并发症.
结论:
- 低剂量rFVIIa与TXA相结合是严重XI因子缺乏症患者泌尿外科手术的可行和有吸引力的选择.
- 该方案证明了安全性和有效性,需要考虑临床实施.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
536
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
536
Extrinsic and Intrinsic Pathways of Hemostasis
3.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
3.6K
Introduction to Hemostasis
3.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
3.9K
Clot Retraction and Fibrinolysis
2.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
2.4K
Coagulation
3.2K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
3.2K
Disorders of Hemostasis
638
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
638


